Functional analyses of RET mutations in Chinese hirschsprung disease patients
✍ Scribed by Thomas Y.Y. Leon; Man-Ting So; Vincent C.H. Lui; Robert M.W. Hofstra; Paul K.H. Tam; Elly S.W. Ngan; Maria-Mercè Garcia-Barceló
- Book ID
- 102757118
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 504 KB
- Volume
- 94
- Category
- Article
- ISSN
- 1542-0752
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND
Hirschsprung disease (HSCR) is a congenital disease characterized by the absence of ganglion cells in various length of distal digestive tract. The rearranged during transfection gene (RET) is considered the major gene in HSCR. Although an increasing number of HSCR‐associated RET coding sequence (CDS) mutations have been identified in recent years, not many have been investigated for functional consequence on the RET protein.
METHODS and RESULTS
We examined the functional implications of the de novo RET‐CDS mutations V145G, Y483X, V636fsX1, and F961L that we first identified in sporadic Chinese patients with HSCR. The V145G disrupted RET glycosylation and F961L RET phosphorylation. Presumably, the truncation mutations would affect the translocation or the anchoring of the RET protein onto the cellular membrane.
CONCLUSION
The study of RET‐CDS mutations that appear de novo is essential not only for understanding the mechanistic of the disease but also for penetrance and recurrence risk estimations, being the ultimate goal for the improvement in disease management and counseling. Birth Defects Research (Part A), 2012. © 2011 Wiley Periodicals, Inc.
📜 SIMILAR VOLUMES
Hirschsprung disease, or congenital aganglionic megacolon, is a genetic disorder of neural crest development affecting 1:5,000 newborns. Mutations in the RET proto-oncogene, repeatedly identified in the heterozygous state in both long-and short-segment Hirschsprung patients, lead to loss of both tra